Literature DB >> 8363352

Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease.

S W Scheff1, L Sparks, D A Price.   

Abstract

We quantified the synaptic density in the entorhinal cortex (Brodmann area 28) in autopsy material from 10 individuals with Alzheimer's disease and compared them to 11 age-matched, postmortem-matched control subjects without dementia, using standard electron microscopy. The statistical data showed no change in synaptic density between control and Alzheimer subjects, in either lamina III or V of the cortex. There were no correlations between synaptic density and synaptic apposition length or density of senile plaques. The entorhinal cortex stands in marked contrast to other cortical areas that show a significant decline in synaptic numbers with Alzheimer's disease. This preservation of synaptic numbers may be related to a plasticity response that is greater in the entorhinal area than in other areas of the cortex.

Entities:  

Mesh:

Year:  1993        PMID: 8363352     DOI: 10.1002/ana.410340309

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

Review 2.  Amyotrophic lateral sclerosis: current and future treatment strategies.

Authors:  B W Festoff
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 3.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

4.  Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.

Authors:  K Blennow; N Bogdanovic; I Alafuzoff; R Ekman; P Davidsson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 5.  Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

6.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

7.  Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation?

Authors:  Eric Guedj; Emmanuel J Barbeau; Mira Didic; Olivier Felician; Catherine de Laforte; Jean-Philippe Ranjeva; Michel Poncet; Patrick J Cozzone; Olivier Mundler; Mathieu Ceccaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-18       Impact factor: 9.236

8.  Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease.

Authors:  Afia Akram; Daniel Christoffel; Anne B Rocher; Constantin Bouras; Enikö Kövari; Daniel P Perl; John H Morrison; François R Herrmann; Vahram Haroutunian; Panteleimon Giannakopoulos; Patrick R Hof
Journal:  Neurobiol Aging       Date:  2007-04-08       Impact factor: 4.673

Review 9.  Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.

Authors:  Makoto Hashimoto; Eliezer Masliah
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 10.  Neuropathology of Alzheimer's disease.

Authors:  Daniel P Perl
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.